Literature DB >> 7059294

Effect of naloxone on the "on-off' syndrome in patients receiving long-term levodopa therapy.

M Trabucchi, S Bassi, L Frattola.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059294     DOI: 10.1001/archneur.1982.00510140054014

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  7 in total

Review 1.  Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Authors:  Mahmoud M Iravani; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

2.  Potential of opioid antagonists in the treatment of levodopa-induced dyskinesias in Parkinson's disease.

Authors:  B Henry; J M Brotchie
Journal:  Drugs Aging       Date:  1996-09       Impact factor: 3.923

3.  Endomorphin-1: induction of motor behavior and lack of receptor desensitization.

Authors:  A Mehta; G Bot; T Reisine; M F Chesselet
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

4.  Sleep pattern alterations by naloxone. Partial prevention by haloperidol.

Authors:  C Cianchetti; C Masala; P Olivari; G Giordano
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Presynaptic modulation of synaptic transmission by opioid receptor in rat subthalamic nucleus in vitro.

Authors:  Ke-Zhong Shen; Steven W Johnson
Journal:  J Physiol       Date:  2002-05-15       Impact factor: 5.182

Review 6.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

7.  Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys.

Authors:  R J Vermeulen; B Drukarch; M C Sahadat; C Goosen; A N Schoffelmeer; E C Wolters; J C Stoof
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.